LRRK2 and Parkinson disease: Overall, these data indicate that LRRK2 is involved in the cellular pathways induced by inflammation, and that LRRK2 R1441G mutation might push microglia toward a pro-inflammatory state, which results, in turn, in exacerbated inflammation and consequent neurodegeneration in patients with PD (Figure 1).